BEAM
Beam Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$27.23
−5.58%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- 0.03x
- Debt / assets
- 0.18x
- Debt / EBITDA
- -3.91x
- Net debt / EBITDA
- -0.44x
Liquidity & coverage
- Current ratio
- 14.57x
- Quick ratio
- 14.57x
- Cash ratio
- 14.25x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $1.1B
Cash & dividend
- FCF / debt
- -1.51x
- Cash flow / debt
- -1.45x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- -75.0%
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026